Market Overview:
The global hydroxyapatite-coated femoral components market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of osteoarthritis and other joint diseases, rising geriatric population, and technological advancements in the field of orthopedics. The global hydroxyapatite-coated femoral components market is segmented on the basis of type into primary and revision femoral components. The primary femoral component segment is expected to account for a larger share of the global hydroxyapatite-coated femoral components market than the revision component segment during the forecast period from 2018 to 2030. This can be attributed to factors such as increasing demand for total hip replacement surgeries due to rising incidence of osteoarthritis and other joint diseases, growing geriatric population, and technological advancements in orthopedics surgery procedures. On the basis of application, hospitals are expected to account for a larger share of the global hydroxyapatite-coated femoral components market than clinics duringthe forecast period from 2018to2030.
Product Definition:
A hydroxyapatite-coated femoral component is a medical device that is implanted into the femur of a patient to replace a damaged or diseased bone. The hydroxyapatite coating helps to promote bone growth and integration between the implant and the surrounding tissue. This can help to improve the longevity and functionality of the implant.
Primary:
The global market for primary bone cement, also known as hydroxyapatite coatings or HA-coated femoral components, is expected to witness significant growth over the forecast period. Primary bone cement consists of calcium and phosphate ions that react with each other to form a hard coating on the surface of bones. The reaction occurs when an acid (such as vinegar) or alkali (such as baking soda) is applied along with the primary agent on a clean bone surface.
Revision:
A revision arthroplasty is a surgical procedure to correct defects in the knee or hip. The main objective of this surgery is to restore the function of damaged joints and reduce pain. Revision (revision arthroplasty) helps in reducing chronic pain after an initial operation for arthritis, osteoarthritis, or rheumatoid arthritis has failed.
The global market for revision.
Application Insights:
The market is segmented by application into hospital, clinic and others. The hospital segment dominated the overall industry in terms of revenue in 2017. This can be attributed to factors such as rising cases of trauma and increasing government funding for the improvement of healthcare infrastructure across countries such as India, China and Brazil. Furthermore, growing awareness about advanced treatment options for knee implants among consumers is expected to boost product demand over the forecast period.
Hydroxyapatite-coated femoral components have a high success rate in reducing pain after surgery owing to its anti-inflammatory properties that help reduce swelling at the site of injury or damage to soft tissue structures caused due to osteochondral defect repair procedures (such as total knee arthroplasty).
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare expenditure levels in North America are some factors responsible for its large share. In addition, favorable reimbursement policies offered by governments and health insurance providers are anticipated to further increase the penetration rate of hip replacement surgeries over the forecast period.
Asia Pacific is expected to witness a lucrative growth rate during the forecast period owing to rising disposable income levels and improving standard of living resulting from economic development in emerging countries such as China and India. Furthermore, increasing medical tourism due to low cost compared with developed economies is also expected to drive demand for hydroxyapatite coated components over the next eight years.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The Hydroxyapatite-coated Femoral Components market is expected to benefit from the increasing demand for minimally invasive surgeries. This is because the use of these components helps in reducing surgical trauma and also leads to shorter hospital stays.
- Rising geriatric population: The global geriatric population is rising at a rapid pace and this is expected to drive the Hydroxyapatite-coated Femoral Components market as elderly patients are more prone to orthopedic diseases and require hip replacement surgeries for relief.
- Technological advancements: The Hydroxyapatite-coated Femoral Components market is witnessing rapid technological advancements, which are helping manufacturers introduce new products with better features into the market. This is likely to boost the overall growth of the market in coming years.
- Growing awareness about benefits of hydroxyapatite coated femoral components: There has been a growing awareness among surgeons and patients about the benefits of using hydroxyapatite coated femoral components in hip replacement surgeries, which is aiding in driving demand for these products globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hydroxyapatite-coated Femoral Components Market Research Report
By Type
Primary, Revision
By Application
Hospital, Clinic
By Companies
Zimmer Biomet, Stryker, Nano Interface Technology, DePuy Synthes, Smith & Nephew, MicroPort, Exactech, Kycera Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Hydroxyapatite-coated Femoral Components Market Report Segments:
The global Hydroxyapatite-coated Femoral Components market is segmented on the basis of:
Types
Primary, Revision
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zimmer Biomet
- Stryker
- Nano Interface Technology
- DePuy Synthes
- Smith & Nephew
- MicroPort
- Exactech
- Kycera Medical
Highlights of The Hydroxyapatite-coated Femoral Components Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Primary
- Revision
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hydroxyapatite-coated Femoral Components Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hydroxyapatite-coated femoral components are implants that are coated with hydroxyapatite. This helps to improve the durability of the implant and may help to reduce the risk of infection.
Some of the key players operating in the hydroxyapatite-coated femoral components market are Zimmer Biomet, Stryker, Nano Interface Technology, DePuy Synthes, Smith & Nephew, MicroPort, Exactech, Kycera Medical.
The hydroxyapatite-coated femoral components market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hydroxyapatite-coated Femoral Components Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hydroxyapatite-coated Femoral Components Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hydroxyapatite-coated Femoral Components Market - Supply Chain
4.5. Global Hydroxyapatite-coated Femoral Components Market Forecast
4.5.1. Hydroxyapatite-coated Femoral Components Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hydroxyapatite-coated Femoral Components Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hydroxyapatite-coated Femoral Components Market Absolute $ Opportunity
5. Global Hydroxyapatite-coated Femoral Components Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Type
5.3.1. Primary
5.3.2. Revision
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hydroxyapatite-coated Femoral Components Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hydroxyapatite-coated Femoral Components Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hydroxyapatite-coated Femoral Components Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hydroxyapatite-coated Femoral Components Demand Share Forecast, 2019-2026
9. North America Hydroxyapatite-coated Femoral Components Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Type
9.7.1. Primary
9.7.2. Revision
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hydroxyapatite-coated Femoral Components Demand Share Forecast, 2019-2026
10. Latin America Hydroxyapatite-coated Femoral Components Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Type
10.7.1. Primary
10.7.2. Revision
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hydroxyapatite-coated Femoral Components Demand Share Forecast, 2019-2026
11. Europe Hydroxyapatite-coated Femoral Components Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Type
11.7.1. Primary
11.7.2. evision
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hydroxyapatite-coated Femoral Components Demand Share, 2019-2026
12. Asia Pacific Hydroxyapatite-coated Femoral Components Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Type
12.7.1. Primary
12.7.2. Revision
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hydroxyapatite-coated Femoral Components Demand Share, 2019-2026
13. Middle East & Africa Hydroxyapatite-coated Femoral Components Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hydroxyapatite-coated Femoral Components Market Size and Volume Forecast by Type
13.7.1. Primary
13.7.2. Revision
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hydroxyapatite-coated Femoral Components Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hydroxyapatite-coated Femoral Components Market: Market Share Analysis
14.2. Hydroxyapatite-coated Femoral Components Distributors and Customers
14.3. Hydroxyapatite-coated Femoral Components Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Zimmer Biomet
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Stryker
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Nano Interface Technology
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. DePuy Synthes
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Smith & Nephew
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. MicroPort
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Exactech
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Kycera Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
